Prepared as a catalog companion to the model testing report.
Ingredient list
Declared composition for a LIRAVEXIN catalog item — not a tested result
Declared ingredients
| Ingredient | Amount as declared | Public identity |
|---|---|---|
| LL-37 | 5 mg | The 37-residue C-terminal antimicrobial peptide of human cathelicidin (hCAP18). Public sequence / structure: Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) |
| Other constituents | — | Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here. |
Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.
Permalink
The QR code on the model report opens this page.
Published address:
https://gs-laboratory.com/ingredients/375.html
This is the published address of this ingredient list.
Notes
This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.
The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.